Crucially, cancer cells can adapt to elevated ROS levels by increasing the activity of endogenous antioxidant systems, such as glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), and the thioredoxin (Trx) system. Here, TXN is linked to cancer.